Detection of MboII Polymorphism at the 5′ Promoter Region of CYP3A4-Reference-Cited by-同舟云学术

Detection of MboII Polymorphism at the 5′ Promoter Region of CYP3A4

Published:2001-02-01 Issue:2 Volume:47 Page:348-351
ISSN:0009-9147
Container-title:Clinical Chemistry
language:en
Short-container-title:

Author:

Cavalli Selma A,Hirata Mario H¹,Hirata Rosario D C¹

Affiliation:

1. Department of Clinical and Toxicological Analysis, Faculty of Pharmaceutical Sciences of the Sao Paulo University, Av. Lineu Prestes 580, B17, CEP 05508-900, Sao Paulo, SP, Brazil

Publisher

Oxford University Press (OUP)

Subject

Biochemistry, medical,Clinical Biochemistry

Link

http://academic.oup.com/clinchem/article-pdf/47/2/348/32728170/clinchem0348.pdf

Reference14 articles.

1. The P450 Superfamily: Update on New Sequences, Gene Mapping, Accession Numbers, Early Trivial Names of Enzymes, and Nomenclature

2. Pharmacogenetics: a laboratory tool for optimizing therapeutic efficiency

3. Characterization of mRNA Species Related to Human Liver Cytochrome P-450 Nifedipine Oxidase and the Regulation of Catalytic Activity

4. Isolation and sequence determination of a cDNA clone related to human cytochrome P-450 nifedipine oxidase.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of CYP3A4-392A/G, CYP3A5-6986A/G, and ABCB1-3435C/T Polymorphisms with Tacrolimus Dose, Serum Concentration, and Biochemical Parameters in Mexican Patients with Kidney Transplant;Genes;2024-04-16

2. Preliminary Pharmacogenomic-Based Predictive Models of Tamoxifen Response in Hormone-dependent Chilean Breast Cancer Patients;Frontiers in Pharmacology;2021-11-25

3. Effect of CYP3A4*22 and CYP3A4*1B but not CYP3A5*3 polymorphisms on tacrolimus pharmacokinetic model in Tunisian kidney transplant;Toxicology and Applied Pharmacology;2020-06

4. Influence of combined CYP3A4 and CYP3A5 single-nucleotide polymorphisms on tacrolimus exposure in kidney transplant recipients: a study according to the post-transplant phase;Pharmacogenomics;2015-12

5. Influence of UGT2B7, CYP3A4, and OPRM1 Gene Polymorphisms on Transdermal Buprenorphine Pain Control in Patients with Critical Lower Limb Ischemia Awaiting Revascularization;Pain Practice;2015-09-26